Increasing value and reducing waste in biomedical research: Who's listening?

David Moher, Paul Glasziou, Iain Chalmers, Mona Nasser, Patrick M M Bossuyt, Daniël A. Korevaar, Ian D. Graham, Philippe Ravaud, Isabelle Boutron

Research output: Contribution to journalReview articleResearchpeer-review

130 Citations (Scopus)

Abstract

The biomedical research complex has been estimated to consume almost a quarter of a trillion US dollars every year. Unfortunately, evidence suggests that a high proportion of this sum is avoidably wasted. In 2014, The Lancet published a series of five reviews showing how dividends from the investment in research might be increased from the relevance and priorities of the questions being asked, to how the research is designed, conducted, and reported. 17 recommendations were addressed to five main stakeholders-funders, regulators, journals, academic institutions, and researchers. This Review provides some initial observations on the possible effects of the Series, which seems to have provoked several important discussions and is on the agendas of several key players. Some examples of individual initiatives show ways to reduce waste and increase value in biomedical research. This momentum will probably move strongly across stakeholder groups, if collaborative relationships evolve between key players; further important work is needed to increase research value. A forthcoming meeting in Edinburgh, UK, will provide an initial forum within which to foster the collaboration needed.

Original languageEnglish
Pages (from-to)1573-1586
Number of pages14
JournalThe Lancet
Volume387
Issue number10027
DOIs
Publication statusPublished - 9 Apr 2016

Fingerprint

Biomedical Research
Research
Research Personnel

Cite this

Moher, D., Glasziou, P., Chalmers, I., Nasser, M., Bossuyt, P. M. M., Korevaar, D. A., ... Boutron, I. (2016). Increasing value and reducing waste in biomedical research: Who's listening? The Lancet, 387(10027), 1573-1586. https://doi.org/10.1016/S0140-6736(15)00307-4
Moher, David ; Glasziou, Paul ; Chalmers, Iain ; Nasser, Mona ; Bossuyt, Patrick M M ; Korevaar, Daniël A. ; Graham, Ian D. ; Ravaud, Philippe ; Boutron, Isabelle. / Increasing value and reducing waste in biomedical research: Who's listening?. In: The Lancet. 2016 ; Vol. 387, No. 10027. pp. 1573-1586.
@article{3dabfa7199eb43ed83849ce2114c3985,
title = "Increasing value and reducing waste in biomedical research: Who's listening?",
abstract = "The biomedical research complex has been estimated to consume almost a quarter of a trillion US dollars every year. Unfortunately, evidence suggests that a high proportion of this sum is avoidably wasted. In 2014, The Lancet published a series of five reviews showing how dividends from the investment in research might be increased from the relevance and priorities of the questions being asked, to how the research is designed, conducted, and reported. 17 recommendations were addressed to five main stakeholders-funders, regulators, journals, academic institutions, and researchers. This Review provides some initial observations on the possible effects of the Series, which seems to have provoked several important discussions and is on the agendas of several key players. Some examples of individual initiatives show ways to reduce waste and increase value in biomedical research. This momentum will probably move strongly across stakeholder groups, if collaborative relationships evolve between key players; further important work is needed to increase research value. A forthcoming meeting in Edinburgh, UK, will provide an initial forum within which to foster the collaboration needed.",
author = "David Moher and Paul Glasziou and Iain Chalmers and Mona Nasser and Bossuyt, {Patrick M M} and Korevaar, {Dani{\"e}l A.} and Graham, {Ian D.} and Philippe Ravaud and Isabelle Boutron",
year = "2016",
month = "4",
day = "9",
doi = "10.1016/S0140-6736(15)00307-4",
language = "English",
volume = "387",
pages = "1573--1586",
journal = "Lancet",
issn = "0140-6736",
publisher = "Elsevier",
number = "10027",

}

Moher, D, Glasziou, P, Chalmers, I, Nasser, M, Bossuyt, PMM, Korevaar, DA, Graham, ID, Ravaud, P & Boutron, I 2016, 'Increasing value and reducing waste in biomedical research: Who's listening?' The Lancet, vol. 387, no. 10027, pp. 1573-1586. https://doi.org/10.1016/S0140-6736(15)00307-4

Increasing value and reducing waste in biomedical research: Who's listening? / Moher, David; Glasziou, Paul; Chalmers, Iain; Nasser, Mona; Bossuyt, Patrick M M; Korevaar, Daniël A.; Graham, Ian D.; Ravaud, Philippe; Boutron, Isabelle.

In: The Lancet, Vol. 387, No. 10027, 09.04.2016, p. 1573-1586.

Research output: Contribution to journalReview articleResearchpeer-review

TY - JOUR

T1 - Increasing value and reducing waste in biomedical research: Who's listening?

AU - Moher, David

AU - Glasziou, Paul

AU - Chalmers, Iain

AU - Nasser, Mona

AU - Bossuyt, Patrick M M

AU - Korevaar, Daniël A.

AU - Graham, Ian D.

AU - Ravaud, Philippe

AU - Boutron, Isabelle

PY - 2016/4/9

Y1 - 2016/4/9

N2 - The biomedical research complex has been estimated to consume almost a quarter of a trillion US dollars every year. Unfortunately, evidence suggests that a high proportion of this sum is avoidably wasted. In 2014, The Lancet published a series of five reviews showing how dividends from the investment in research might be increased from the relevance and priorities of the questions being asked, to how the research is designed, conducted, and reported. 17 recommendations were addressed to five main stakeholders-funders, regulators, journals, academic institutions, and researchers. This Review provides some initial observations on the possible effects of the Series, which seems to have provoked several important discussions and is on the agendas of several key players. Some examples of individual initiatives show ways to reduce waste and increase value in biomedical research. This momentum will probably move strongly across stakeholder groups, if collaborative relationships evolve between key players; further important work is needed to increase research value. A forthcoming meeting in Edinburgh, UK, will provide an initial forum within which to foster the collaboration needed.

AB - The biomedical research complex has been estimated to consume almost a quarter of a trillion US dollars every year. Unfortunately, evidence suggests that a high proportion of this sum is avoidably wasted. In 2014, The Lancet published a series of five reviews showing how dividends from the investment in research might be increased from the relevance and priorities of the questions being asked, to how the research is designed, conducted, and reported. 17 recommendations were addressed to five main stakeholders-funders, regulators, journals, academic institutions, and researchers. This Review provides some initial observations on the possible effects of the Series, which seems to have provoked several important discussions and is on the agendas of several key players. Some examples of individual initiatives show ways to reduce waste and increase value in biomedical research. This momentum will probably move strongly across stakeholder groups, if collaborative relationships evolve between key players; further important work is needed to increase research value. A forthcoming meeting in Edinburgh, UK, will provide an initial forum within which to foster the collaboration needed.

UR - http://www.scopus.com/inward/record.url?scp=84945577445&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(15)00307-4

DO - 10.1016/S0140-6736(15)00307-4

M3 - Review article

VL - 387

SP - 1573

EP - 1586

JO - Lancet

JF - Lancet

SN - 0140-6736

IS - 10027

ER -

Moher D, Glasziou P, Chalmers I, Nasser M, Bossuyt PMM, Korevaar DA et al. Increasing value and reducing waste in biomedical research: Who's listening? The Lancet. 2016 Apr 9;387(10027):1573-1586. https://doi.org/10.1016/S0140-6736(15)00307-4